Search Results
Dr. Logan Discusses Treatment Options in CLL
Dr. Logan Discusses Ibrutinib Plus Venetoclax in CLL
Treatment options for the young CLL patient with deletion 17p: Do they need a different approach?
Selecting the best treatment option in CLL
Dr. Jacobs Discusses the Frontline Treatment of CLL
Acalabrutinib’s Role in Treating Chronic Lymphocytic Leukemia
Deciding on CLL Therapy and When to Treat
Dr. Matthew Davids on advances in CLL treatment | Dana-Farber Cancer Institute
Dr. Kay Discusses the Role of Acalabrutinib in CLL
The current role of acalabrutinib in the treatment of CLL
Dr. Kay Discusses the Role of Ibrutinib in CLL
Combining Targeted Therapies in CLL
